Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Selman MH, de Jong SE, Soonawala D, Kroon FP, Adegnika AA, Deelder AM, Hokke CH, Yazdanbakhsh M, Wuhrer M.

Mol Cell Proteomics. 2012 Apr;11(4):M111.014563. doi: 10.1074/mcp.M111.014563. Epub 2011 Dec 19.

2.

IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.

Selman MH, Niks EH, Titulaer MJ, Verschuuren JJ, Wuhrer M, Deelder AM.

J Proteome Res. 2011 Jan 7;10(1):143-52. doi: 10.1021/pr1004373. Epub 2010 Jul 30.

PMID:
20672848
3.

Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.

Selman MH, Derks RJ, Bondt A, Palmblad M, Schoenmaker B, Koeleman CA, van de Geijn FE, Dolhain RJ, Deelder AM, Wuhrer M.

J Proteomics. 2012 Feb 2;75(4):1318-29. doi: 10.1016/j.jprot.2011.11.003. Epub 2011 Nov 15.

PMID:
22120122
4.

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.

Fokkink WJ, Selman MH, Dortland JR, Durmuş B, Kuitwaard K, Huizinga R, van Rijs W, Tio-Gillen AP, van Doorn PA, Deelder AM, Wuhrer M, Jacobs BC.

J Proteome Res. 2014 Mar 7;13(3):1722-30. doi: 10.1021/pr401213z. Epub 2014 Feb 17.

PMID:
24533874
5.

Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.

Bondt A, Rombouts Y, Selman MH, Hensbergen PJ, Reiding KR, Hazes JM, Dolhain RJ, Wuhrer M.

Mol Cell Proteomics. 2014 Nov;13(11):3029-39. doi: 10.1074/mcp.M114.039537. Epub 2014 Jul 8.

6.

High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.

Baković MP, Selman MH, Hoffmann M, Rudan I, Campbell H, Deelder AM, Lauc G, Wuhrer M.

J Proteome Res. 2013 Feb 1;12(2):821-31. doi: 10.1021/pr300887z. Epub 2013 Jan 18.

PMID:
23298168
7.

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis.

Kemna MJ, Plomp R, van Paassen P, Koeleman CA, Jansen BC, Damoiseaux JG, Cohen Tervaert JW, Wuhrer M.

EBioMedicine. 2017 Mar;17:108-118. doi: 10.1016/j.ebiom.2017.01.033. Epub 2017 Jan 28.

8.

Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.

Kodar K, Stadlmann J, Klaamas K, Sergeyev B, Kurtenkov O.

Glycoconj J. 2012 Jan;29(1):57-66. doi: 10.1007/s10719-011-9364-z. Epub 2011 Dec 17.

PMID:
22179780
9.

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.

Wuhrer M, Selman MH, McDonnell LA, Kümpfel T, Derfuss T, Khademi M, Olsson T, Hohlfeld R, Meinl E, Krumbholz M.

J Neuroinflammation. 2015 Dec 18;12:235. doi: 10.1186/s12974-015-0450-1.

10.

Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.

Hills AE, Patel A, Boyd P, James DC.

Biotechnol Bioeng. 2001 Oct 20;75(2):239-51.

PMID:
11536148
11.

Fc-glycosylation of IgG1 is modulated by B-cell stimuli.

Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, Deelder AM, Huizinga TW, Toes RE, Wuhrer M.

Mol Cell Proteomics. 2011 May;10(5):M110.004655. doi: 10.1074/mcp.M110.004655. Epub 2011 Mar 3.

12.

Glycomic signatures on serum IgGs for prediction of postvaccination response.

Wang JR, Guan WD, Yau LF, Gao WN, Zhan YQ, Liu L, Yang ZF, Jiang ZH.

Sci Rep. 2015 Jan 23;5:7648. doi: 10.1038/srep07648.

13.

Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G.

Einarsdottir HK, Selman MH, Kapur R, Scherjon S, Koeleman CA, Deelder AM, van der Schoot CE, Vidarsson G, Wuhrer M.

Glycoconj J. 2013 Feb;30(2):147-57. doi: 10.1007/s10719-012-9381-6. Epub 2012 May 10.

14.

Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum.

Wuhrer M, Stam JC, van de Geijn FE, Koeleman CA, Verrips CT, Dolhain RJ, Hokke CH, Deelder AM.

Proteomics. 2007 Nov;7(22):4070-81.

PMID:
17994628
15.

Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.

Wuhrer M, Stavenhagen K, Koeleman CA, Selman MH, Harper L, Jacobs BC, Savage CO, Jefferis R, Deelder AM, Morgan M.

J Proteome Res. 2015 Apr 3;14(4):1657-65. doi: 10.1021/pr500780a. Epub 2015 Mar 24.

PMID:
25761865
16.

Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.

de Haan N, Reiding KR, Driessen G, van der Burg M, Wuhrer M.

J Proteome Res. 2016 Jun 3;15(6):1853-61. doi: 10.1021/acs.jproteome.6b00038. Epub 2016 May 19.

PMID:
27161864
17.

Change in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential.

Chen G, Wang Y, Qin X, Li H, Guo Y, Wang Y, Liu H, Wang X, Song G, Li F, Li F, Guo S, Qiu L, Li Z.

Electrophoresis. 2013 Aug;34(16):2407-16. doi: 10.1002/elps.201200455. Epub 2013 Jul 26.

PMID:
23766031
18.

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.

Reusch D, Haberger M, Falck D, Peter B, Maier B, Gassner J, Hook M, Wagner K, Bonnington L, Bulau P, Wuhrer M.

MAbs. 2015;7(4):732-42. doi: 10.1080/19420862.2015.1045173.

19.

Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.

Kapur R, Della Valle L, Verhagen OJ, Hipgrave Ederveen A, Ligthart P, de Haas M, Kumpel B, Wuhrer M, van der Schoot CE, Vidarsson G.

Transfusion. 2015 Mar;55(3):553-62. doi: 10.1111/trf.12880. Epub 2014 Sep 19.

PMID:
25234110
20.

The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.

Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, Lellouch AC, Rudd PM, Woof JM, Dwek RA.

J Biol Chem. 1998 Jan 23;273(4):2260-72.

Supplemental Content

Support Center